Effects of ageing and dehydroepiandrosterone administration on pro-opiomelanocortin mRNA expression in the anterior and intermediate lobes of the rat pituitary

Journal of Neuroendocrinology

Volumn 11, Issue 9, 1999, Pages 737-742

  Givalois, L ^b   Li, S ^a   Pelletier, Georges ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIV MONTPELLIER   (France)

Author keywords

Ageing; Dehydroepiandrosterone; Hypothalamo pituitary adrenocortical axis; Pituitary; Pro opiomelanocortin

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; MESSENGER RNA; PRASTERONE; PROOPIOMELANOCORTIN;

ADENOHYPOPHYSIS; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; FEMALE; HYBRIDIZATION; HYPOPHYSIS INTERMEDIATE LOBE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MESSENGER RNA SYNTHESIS; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

AGING; ANIMALS; DEHYDROEPIANDROSTERONE; FEMALE; MALE; PITUITARY GLAND; PITUITARY GLAND, ANTERIOR; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; SEX CHARACTERISTICS; TISSUE DISTRIBUTION;

EID: 0032778018     PISSN: 09538194     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2826.1999.00392.x     Document Type: Article

References (38)

1. Oxenkrug GF, Pomara N, McIntyre IM, Branconnier RJ, Stanley M, Gershon S. Aging and cortisol resistance to suppression by dexamethasone: a positive Correlation. Psychiatry Res 1983; 10: 125-130.
2. Halbreich U, Asnis GM, Zumoff B, Nathan RS, Shindledecker R. Effect of age and sex on cortisol secretion in depressives and normals. Psychiatry Res 1984; 13: 221-229.
3. Ohashi M, Fujio N, Kato K, Nawata H, Ibayashi H. Aging is without effect on pituitary-adrenal system in men. Gerontology 1986; 32: 335-339.
4. Waltman C, Blackman MR, Chrousos GP, Riemann C, Harman SM. Spontaneous and glucocorticoid-inhibited adrenocorticotropic hormone and cortisol secretion are similar in healthy young and old men. J Clin Endocrinol Metab 1991; 73: 495-502.
5. Chiueh CC, Nespor SM, Smith MS. Mammalian aging: theoretical implications of changes in brain and endocrine systems during mid-late-life. Peptides 1980; 1: 185-188.
6. Sapolsky RM, Krey LC, McEwen BS. The pituitary-adrenal response to novel stimulation and ether stress in young adult and aged rats. Exp Gerontol 1983; 18: 55-64.
7. Hess GD, Riegle GD. Adrenocortical responsiveness to stress and ACTH in aging rats, J. Gerontol 1970; 25: 354-358.
8. Popplewell PY, Tsubokawa M, Ramachandran J, Axhar S. Differential effects of aging on adrenocorticotropin receptors, adenosine 3′, 5′-monophosphate response, and corticosterone secretion in adrenocortical cells from Sprague-Dawley rats. Endocrinology 1986; 119: 2206-2213.
9. Thomas G, Frenoy N, Legrain S, Sebag-Lanoe R, Baulieu EE, Debuire B. Serum dehydroepiandrosterone sulfate levels as an individual marker, J. Clin Endocrinol Metab 1994; 79: 1273-1276.
10. O'Malley BW. Steroid hormone action in eucaryotic cells, J. Clin Invest 1984; 74: 307-312.
11. Daynes RA, Araneo BA. Prevention and reversal of some age-associated changes in immunologic responses by supplemental dehydroepiandrosterone sulfate therapy. Aging Immun Infect Dis 1992; 3: 135-154.
12. Gordon GB, Bush DE, Weisman HF. Reduction of atherosclerosis by administration of DHEA. J Clin Invest 1988; 82: 712-720.
13. Schwartz AG, Whitcomb JW, Nyce JW, Lewbart ML, Pashko LL. Dehydroepiandrosterone and structural analogs: a new class of cancer chemopreventive agents. Adv Cancer Res 1988; 51: 391-424.
14. Li S, Givalois L, Pelletier G. Role of adrenal and gonadal steroids in the response of GnRH gene expression to the endogenous benzodiazepine ligand octadecaneuropeptide in the male rat. Neuropeptides 1997; 9: 229-233.
15. Givalois L, Li S, Pelletier G. Age-related decrease in the hypothalamic CRH mRNA expression is reduced by dehydroepiandrosterone (DHEA) treatment in male and female rats. Mol Brain Res 1997; 48: 107-114.
16. A receptor complex as evaluated by in situ hybridization in the rat pars intermedia. Mol Brain Res 1997; 750: 277-284.
17. Rivest S, Laflamme N. Neuronal activity and neuropeptide gene transcription in the brains of immune-challenged rats, J. Neuroendocrinology 1995; 7: 501-525.
18. Cai A, Scarbrough K, Hinkle DA, Wise PM. Fetal grafts containing suprachiasmatic nuclei restore the diurnal rhythm of CRH and POMC mRNA in aging rats. Am J Physiol 1997; 273: R1764-R1770.
19. Cizza G, Calogero AE, Brady LS, Bagdy G, Bergamini E, Blackman MR, Chrousos GP, Gold PW. Male Fischer-344/N-rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age. Endocrinology 1994; 134: 1611-1620.
20. Héroux JA, Grigoriadis DE, deSouza EB. Age-related decreases in corticotropin-releasing factor (CRF) receptors in rat brain and anterior pituitary gland. Brain Res 1991; 542: 155-158.
21. Tizabi Y, Aguilera G, Gilad GM. Age-related reduction in pituitary corticotropin-releasing hormone receptors in two rat strains. Neurobiol Aging 1992; 13: 227-230.
22. Conti A, Maestroni G. The clinical neuroimmunotherapeutic role of melatonin in oncology, J. Pineal Res 1995; 19: 103-110.
23. Sonntag WE, Goliszek AG, Brodish A, Eldridge JC. Diminished diurnal secretion of adrenocorticotropin (ACTH), but not corticosterone, in old male rats: possible relation to increased adrenal sensitivity to ACTH in vivo. Endocrinology 1987; 120: 2308-2315.
24. Landfield PW, Sundberg DK, Smith MS. Mammalian aging: Theoretical implications of changes in brain and endocrine system during mid- and late life. Peptides 1989; 1: 185-188.
25. Scaccianone S, DeSciullo A, Angelucci L. Age-related changes in hypothalamo-pituitary-adrenocortical system activity in the rat. Neuroendocrinology 1990; 52: 150-155.
26. Issa AM, Rowe W, Gauthier S, Meaney MJ. Hypothalamic-pituitary-adrenal activity in aged, cognitively impaired and cognitively unimpaired rats. J Neurosci 1990; 10: 3247-3254.
27. Shinoda K. Brain aromatization and its associated structures. Endocrine J 1994; 41: 115-138.
28. Vedder H, Purlow F, Zieglgansberger W, Holsboer F. Neurosteroids do not regulate proopiomelanocortin-gene expression in pituitary cells. Exp Clin Endocrinol 1993; 101: 161-165.
29. Garcia de Yebenes E, Hong M, Pelletier G. Effects of dehydroepiandrosterone (DHEA) on prolactin and arcuate nucleus neuron tyrosine hydroxylase mRNA levels in the rat, J. Neuroendocrinol 1995; 7: 589-595.
30. Hoffmann GE, Sladek JR. Age-related changes in dopamine, LHRH and somatostatin in the rat hypothalamus, Neurobiol Aging 1980; 1: 27-37.
31. Wise PM, Scarbrough K, Larson GH, Lloyd JM, Weiland NG, Chiu S. Neuroendocrine influences on aging of the female reproductive system. Frontiers Neuroendocrinol 1991; 12: 323-356.
32. Lee MT, Anderson E, Lee GY. Changes in ovarian morphology and serum hormones in the rat after treatment with dehydroepiandrosterone. Anal Record 1991; 231: 185-192.
33. Li S, Yan X, Bélanger A, Labrie F. Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz (a) anthracene (DMBA) in the rat. Breast Cancer Res Treat 1993; 29: 203-217.
34. Whitnall MH. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 1993; 40: 573-629.
35. Li S, Givalois L, Pelletier G. Dehydroepiandrosterone administration reverses the inhibitor influence of aging on gonadotropin-releasing hormone gene expression in the male and female rat brain. Endocrine 1997; 6: 265-270.
36. Cleary MP, Seidenstat R, Tanner RH, Schwartz AG. The effects of dehydroepiandrosterone on adipose tissue cellularity in mice. Proc Soc Exp Biol Med 1982; 171: 272-284.
37. Flood JF, Roberts E. Dehydroepiandrosterone sulfate improves memory in aging mice. Brain Res 1988; 448: 178-181.
38. Morales AJ, Nolan JJ, Nelson JC, Yen SSC. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age. J Clin Endocrinol Metab 1994; 78: 1360-1367.